BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zingone F, Siniscalchi M, Savarino EV, Barberio B, Cingolani L, D'Incà R, De Filippo FR, Camera S, Ciacci C. Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study. J Med Internet Res 2020;22:e19574. [PMID: 33006945 DOI: 10.2196/19574] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hayes B, Apputhurai P, Mikocka-Walus A, Barreiro-de Acosta M, Bernstein CN, Burgell R, Burisch J, Bennebroek Evertsz F, Ferreira N, Graff LA, Trindade IA, Gearry R, Lo B, Mokrowiecka A, Moser G, Petrik M, Stengel A, Knowles SR. Extending the Common Sense Model to Explore the Impact of the Fear of COVID-19 on Quality of Life in an International Inflammatory Bowel Disease Cohort. J Clin Psychol Med Settings 2021. [PMID: 34559331 DOI: 10.1007/s10880-021-09823-y] [Reference Citation Analysis]
2 Giansanti D, Morone G, Loreti A, Germanotta M, Aprile I. A Narrative Review of the Launch and the Deployment of Telemedicine in Italy during the COVID-19 Pandemic. Healthcare 2022;10:415. [DOI: 10.3390/healthcare10030415] [Reference Citation Analysis]
3 Sinagra E, Busacca A, Guida L, Carrozza L, Brinch D, Crispino F, Maida M, Battaglia S, Celsa C, Cammà C, Cappello M. Telemedicine Is an Effective Tool to Monitor Disease Activity in IBD Patients in the COVID-19 Era: A Single Centre Experience Based on Objective Data. Gastroenterology Insights 2022;13:117-26. [DOI: 10.3390/gastroent13010013] [Reference Citation Analysis]
4 Román MÁ, Jiménez Yuste V, García Barcenilla S, Ramírez López A, Monzón Manzano E, de la Cruz Benito B, Butta PA, Rivas Pollmar MI, Trelles Martínez R, González Zorrilla E, Martín Salces M, Cebanu T, Butta NV. Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia. Medicina (Kaunas) 2021;57:219. [PMID: 33804346 DOI: 10.3390/medicina57030219] [Reference Citation Analysis]
5 Bertani L, Barberio B, Tricò D, Zanzi F, Maniero D, Ceccarelli L, Marsilio I, Coppini F, Lorenzon G, Mumolo MG, Zingone F, Costa F, Savarino EV. Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak. J Clin Med 2021;10:3270. [PMID: 34362053 DOI: 10.3390/jcm10153270] [Reference Citation Analysis]
6 Schreiber S, Irving PM, Sharara AI, Martín-Arranz MD, Hébuterne X, Penchev P, Danese S, Anthopoulos P, Akhundova-Unadkat G, Baert F. Review: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions. Aliment Pharmacol Ther 2022. [PMID: 35132657 DOI: 10.1111/apt.16781] [Reference Citation Analysis]
7 Sempere L, Bernabeu P, Cameo J, Gutierrez A, Laveda R, García MF, Aguas M, Zapater P, Jover R, Ruiz-Cantero MT, Hofstadt CV. Evolution of the emotional impact in patients with early inflammatory bowel disease during and after Covid-19 lockdown. Gastroenterol Hepatol 2021:S0210-5705(21)00145-X. [PMID: 34023470 DOI: 10.1016/j.gastrohep.2021.03.004] [Reference Citation Analysis]